Serenity Mental Health Centers Introduces TMS Treatment Services in Nocatee
Serenity Mental Health Centers Offers TMS Treatment in Nocatee Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation,…
AOP Health’s Rapiblyk® (landiolol) Becomes Available Through Vizient® Contract
AOP Health’s Rapiblyk® (landiolol) Now Accessible via Vizient® Contract AOP Health US, LLC announced today that Rapiblyk® (landiolol) is now more widely available across the United States through contract with Vizient®,…
Magnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision…
Hims & Hers Adds Affordable Compounded Semaglutide Pills to Weight Loss Portfolio
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month* Hims & Hers Health, Inc. the leading health and wellness platform, today announced…
Press Ganey and Compass Healthcare Publish New e-Book on the Future of Compassionate Care
Press Ganey and Compass Healthcare Launch New e-Book: Intelligence with Empathy: Building the future of compassionate care Press Ganey, an experience measurement provider to over 41,000 healthcare organizations, and Compass Healthcare, a leading…
Health Canada Authorizes Mirum’s LIVMARLI® for PFIC-Related Cholestatic Pruritus Treatment
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) Mirum Pharmaceuticals, Inc. a leading rare disease company, today…
Revvity Introduces Advanced Discovery Platforms and Highlights Latest Innovations at SLAS2026
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate…
Insulet Introduces Omnipod® 5 and Omnipod Discover™ in the Middle East to Advance Diabetes Care
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care Insulet Corporation the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its…
Fujirebio and Sysmex Launch Sales Partnership to Expand Dementia Testing Solutions
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ:…
Leyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention
Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting…
China’s NMPA Approves Promega’s MSI Detection Kit as a Companion Diagnostic for KEYTRUDA®
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III…
FDA Approves Hologic’s Aptima® HPV Assay for Primary Screening, Expanding Cervical Health Offerings
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio Hologic, Inc. announced today that its Aptima® HPV Assay received FDA approval for clinician-collected HPV primary screening.…